Novo Nordisk has taken a beating on the stock market over the past two years, but since March, the sentiment has turned. (Archive photo). Photo: Mads Claus Rasmussen/Ritzau Scanpix
Novo Nordisk stock up over 30% since March
Novo Nordisk’s stock has risen over 30% since reaching a multi-year low in March, driven by the successful US launch of its weight-loss pill, Wegovy. Following FDA approval in December, over two million prescriptions have been written, marking what the company calls its best-ever US product...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?